Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system. 

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

The new study, published in Current Problems in Cardiology, included data from nearly 18,000 adult patients. 

American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 

“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.

Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.

The risk of developing vaccine-related myocarditis, pericarditis or myopericarditis remains very low, researchers wrote. 

U.S. physicians might be missing out on innovative medical research due to the overwhelming amount of reading and clinical work they are faced with, according to a recent survey.

With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.

The Centers for Medicare and Medicaid Services (CMS) is charging forward with its plan to bring Medicare and Medicaid beneficiaries into coordinated care models.